Search Site

Search form

Current Press Releases

All Releases
View Summary Vertex to Announce First Quarter 2014 Financial Results on May 1
Apr 10, 2014
PDF 7.0 KB
View Summary Vertex to Present at the Barclays Global Healthcare Conference on March 11
Mar 6, 2014
PDF 7.3 KB
View Summary U.S. Food and Drug Administration Approves KALYDECO™ (ivacaftor) for Use in Eight Additional Mutations that Cause Cystic Fibrosis
Feb 21, 2014
PDF 19.6 KB
View Summary Vertex to Present at the RBC Global Healthcare Conference on February 25
Feb 20, 2014
PDF 6.9 KB
View Summary Vertex Reports Full-Year and Fourth Quarter 2013 Financial Results and Provides Financial Guidance for 2014
Jan 29, 2014
PDF 65.5 KB
View Summary Vertex Reviews Corporate Strategy and Outlines Key 2014 Business Priorities at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 12, 2014
PDF 26.0 KB
View Summary Vertex Announces Sustained Viral Response Rate (SVR4) Data from All-Oral Study of VX-135 in Combination with Daclatasvir in Hepatitis C
Jan 9, 2014
PDF 11.4 KB
View Summary Vertex Announces Appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President of Global Medicines Development
Jan 8, 2014
PDF 10.2 KB
View Summary Vertex Announces Upcoming Presentation at J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2013 Financial Results
Jan 7, 2014
PDF 7.6 KB
Showing 1-9 of 9 Page: 1